Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[(2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 28-33

  Kinoshita, Mine ^a   Saito, Nobuko ^a   Noto, Tunehisa ^a   Tamaki, Hajime ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(2 DIMETHYLAMINOBENZYL)SULFINYL] 1 (3 METHYL 2 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATASE INHIBITOR; CYCLOHEXIMIDE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; MERCAPTOETHANOL; OMEPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR; T 330; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; INHIBITION KINETICS; INTRADUODENAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; STOMACH ACID SECRETION;

ANIMALS; CYCLOHEXIMIDE; ENZYME INHIBITORS; GASTRIC ACID; GASTRIC MUCOSA; H(+)-K(+)-EXCHANGING ATPASE; IMIDAZOLES; MALE; MERCAPTOETHANOL; OMEPRAZOLE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030439220     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
2. CARLSSON, E., LARSSON, H., MATTSSON, H., RYBERG, B. AND SUNDELL, G.: Pharmacology and toxicology of omeprazole with special reference to the effects on the gastric mucosa. Scand. J. Gastroenterol. 21: suppl. 118, 31-38, 1986.
3. +-ATPase by omeprazole. Biochem. Pharmac. 37: 2543-2549, 1988.
4. GEDDA, K , SCOTT, D., BESANCON, M. AND SACHS, G.: The half life of the H,K ATPase of gastric mucosa. Gastroenterology 106: A79, 1994.
5. +-ATPase inhibitors. Prog. Med. Chem. 31: 233-264, 1994.
6. HERSEY, S. J. AND SACHS, G.: Gastric acid secretion. Physiol. Rev. 75: 155-189, 1995.
7. +)-ATPase in vivo by omeprazole. Biochem. Biophys. Res. Comm 126: 78-82, 1985a.
8. +-activated oxidizing agent of sulfhydryl groups. J. Biol. Chem. 260: 4591-4597, 1985b.
9. LARSSON, H., CARLSSON, E., MATTSSON, H., LUNDELL, L., SUNDLER, F., SUNDELL, G., WALLMARK, B , WATANABE, T. AND HȦKANSON, R.: Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Gastroenterology 90: 391-399, 1986.
10. LEE, H., HȦKANSON, R., KARLSSON, A., MATTSSON, H. AND SUNDLER, F.: Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach. Digestion 51: 125-132, 1992.
11. LINDBERG, P., BRÄDSTRÖM, A., WALLMARK, B., MATTSSON, H., RIKNER, L. AND HOFFMANN, K.: Omeprazole: The first proton pump inhibitor. Med. Res. Rev. 10: 1-54, 1990.
12. LINDBERG, P., NORDBERG, P., ALMINGER, T., BRADSTRÖM, A. AND WALLMARK, B.: The mechanism of action of the gastric acid secretion inhibitor omeprazole. J. Med. Chem. 29: 1327-1329, 1986.
13. + )-ATPase by omeprazole. Biochim. Biophys. Acta 817: 25-32, 1985.
14. +)-ATPase by omeprazole in isolated gastric vesicles requires proton transport. Biochim. Biophys. Acta 897: 41-51, 1987.
15. +-ATPase is correlated with the rate of acid activation of the inhibitor. Biochem. Pharmac. 39: 661-667, 1990.
16. +)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J. Pharmacol. Exp. Ther. 248: 799-805, 1989.
17. +)-ATPase. J. Cell. Biol. 83: 271-283, 1979.
18. SACHS, G.: Gastric H,K-ATPase as therapeutic target. Ann. Rev. Pharmacol. Toxicol. 28: 269-84, 1988.
19. + pump in plasma membranes of hog stomach. J. Biol. Chem. 251: 7690-7698, 1976.
20. +)-ATPase inhibitor. Biochem. Pharmac. 39: 1799-1806, 1990.
21. +)-ATPase within the parietal cell. Biochim. Biophys. Acta 778: 549-558, 1984.
22. - on gastric acid secretion. Am. J. Physiol. 245: G64-G71, 1983.
23. +-ATPase activity. J. Biol. Chem. 260: 13681-13684, 1985.
24. +-ATPase inhibitor. J. Med. Chem. 39: 596-604, 1996.
25. YODA, A. AND HOKIN, L. E.: On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphoshatase from beef brain. Biochem. Biophys. Res. Comm. 40: 880-886, 1970.